Please login to the form below

Not currently logged in
Email:
Password:

US government

This page shows the latest US government news and features for those working in and with pharma, biotech and healthcare.

New centre aims to Catapult UK into cell and gene therapy lead

New centre aims to Catapult UK into cell and gene therapy lead

The architects of this strategy, including the government, should get credit for getting us to this position.". ... The Cell and Gene Catapult has been backed by more than £60m in government funding, with 160 of its own in-house experts.

Latest news

More from news
Approximately 2 fully matching, plus 193 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified across 15 states of the USA. ... Alongside this, there have been equally important initiatives by the World Health Organization (WHO),

  • US health reforms US health reforms

    US health reforms. Is the stage set for price controls in the US? ... Meanwhile, the global industry waits with bated breath upon a recently elected, mercurial US federal government that whipsaws from one extreme to the other, sometimes within the hour.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    The only ‘fact’is that ‘Brexit means Brexit’… so the Government tell us. ... Two post-referendum announcements have boosted the UK Government. GSK announced a £275 million investment in its UK manufacturing sites and Alnylam, a US biotech

  • Deal Watch August 2016 Deal Watch August 2016

    At the time Deal Watch commented: “ Hopefully Pfizer has finally got the message from the US Government and will now focus on developing its long term business as a leading pharmaceutical ... 624. Advaxis (US). Amgen (US). Licence. ADXS-NEO,

  • Deal Watch April 2016 Deal Watch April 2016

    Winners and losers of the Pfizer/Allergan Fiasco. Winners. Losers. US Government (possibly short term gain). ... This time it is not a Big Pharma deal being blocked by US Government but a Big Pharma deal (by Sanofi ) blocked by Biotech (Medivation).

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Portland Health appoints Alfred Jackson as a partner Portland Health appoints Alfred Jackson as a partner

    In addition to his work in healthcare, Jackson also has broad experience in public affairs and government relations. ... agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our offering to

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    Former Sanofi exec Joseph Devaney joins Astellas. He becomes government affairs and policy, Americas VP. ... In this role, Devaney will be responsible for developing, communicating and implementing Astellas' federal and state government strategies in the

  • Pfizer’s CMO joins board of Tenet Pfizer’s CMO joins board of Tenet

    US healthcare services company Tenet Health Corporation has added pharma experience to its board with the appointment of Pfizer's chief medical officer as director. ... In addition to her role at Pfizer Dr Lewis-Hall was appointed by the US Government to

  • Sanofi appoints NIH’s Gary Nabel as chief scientific officer Sanofi appoints NIH’s Gary Nabel as chief scientific officer

    Sanofi appoints NIH’ s Gary Nabel as chief scientific officer. He previously headed vaccine research centre of the US National Institute of Allergy and Infectious Diseases. ... Dr Nabel leaves the NIH, which is part of the US government's department of

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Could hackers threaten your health?

    In this year’ s Def Con hacking conference, representatives from the US FDA, the government body responsible for the security of medical devices, spoke for the first time.

  • To track disease, follow the money

    of US banknotes, which are carried and passed on by people in the same way as disease. ... Lower-denomination banknotes are more likely to be contaminated (perhaps because they are more widely handled).(7) A US government survey found that that 94% of $1

  • Packer Forbes News January 2016

    She is a graduate in Politics and Parliamentary Studies from the University of Leeds, where she gained first-hand insight into the UK and US government health systems during her placement

  • To track disease, follow the money

    of US banknotes, which are carried and passed on by people in the same way as disease. ... Lower-denomination banknotes are more likely to be contaminated (perhaps because they are more widely handled).(7) A US government survey found that that 94% of $1

  • Focus on Rare Diseases

    The US government passed the Orphan Drug Act in 1983, and it was subsequently adopted in other key markets, most notably in Japan in 1993 and the European Union in 2000.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics